2019-12-19T09:27:32-06:00 2019-06-30 GRANT THORNTON LLP 171 N CLARK ST SUITE 200 CHICAGO IL 60601 990 2018-07-01 133039601 Alzheimer's Disease & Related Disorders Association Inc % RICHARD HOVLAND COO/CFO ALZH 3123558700 225 N Michigan Ave 17th Floor Chicago IL 606017633 RICHARD H HOVLAND COO/CFO & ASST TREAS 3123355771 2019-12-19 true Bridget T Roche P00666837 3128560200 65.229.29.128 36941220193535000000 2019-12-19 P 6A114492425344B191C5A256E0FD2BCC7BB222A4 DB64C1701B389F151E46C096E2734789DEA2CBCD 2018 2020-04-17 16:48:07Z RICHARD H HOVLAND 225 N Michigan Ave 17th Fl Chicago IL 606017633 427457430 false X www.alz.org X 1980 DE ELIMINATE ALZHEIMER'S DISEASE THROUGH THE ADVANCEMENT OF RESEARCH, PROVIDE & ENHANCE CARE & SUPPORT FOR ALL AFF- ECTED & REDUCE THE RISK OF DEMENTIA THROUGH PROMOTION OF BRAIN HEALTH. 28 28 2620 62168 0 353173 321309088 365557820 10504180 9518813 6410118 10191501 7235241 4397744 345458627 389665878 39557360 52340877 0 0 173396038 182430888 1306686 1573775 72213608 145317383 150228333 359577467 386573873 -14118840 3092005 354052059 377644348 97847369 114820016 256204690 262824332 X THE ALZHEIMER'S ASSOCIATION IS THE LEADING VOLUNTARY HEALTH ORGANIZATION IN ALZHEIMER CARE, SUPPORT, AND RESEARCH. (MISSION CONTINUED IN SCHEDULE O). false false 208779081 2675863 2661695 PUBLIC AWARENESS AND EDUCATION - ALZHEIMER'S IS A PROGRESSIVE, DEGENERATIVE AND ULTIMATELY FATAL DISEASE. TOO FEW AMERICANS UNDERSTAND THE CURRENT AND FUTURE ECONOMIC IMPACT OF ALZHEIMER'S. ALREADY MORE THAN 5 MILLION AMERICANS ARE LIVING WITH ALZHEIMER'S AND AS MANY AS 15 MILLION PEOPLE ARE PROVIDING UNPAID CARE AND SUPPORT. AND THIS MASSIVE GROUP IS IN NEED OF INFORMATION AND RESOURCES. THE ALZHEIMER'S ASSOCIATION HAS INVESTED IN EDUCATION CAMPAIGNS AND INITIATIVES TO INCREASE KNOWLEDGE ABOUT ALZHEIMER'S DISEASE AND AWARENESS OF THE ALZHEIMER'S ASSOCIATION COMMUNICATING OUR ROLE AS LEADERS OF THE CAUSE. KEY MESSAGES INCLUDE THE IMPORTANCE OF EARLY DETECTION, RESOURCES FOR PEOPLE WITH ALZHEIMER'S AND THEIR FAMILIES, AND THE SOCIETAL IMPACT OF THE DISEASE. MILLIONS OF CONSTITUENTS PARTICIPATED IN OUR PROGRAMS IN LOCAL COMMUNITIES AND ON-LINE. 59090067 42575672 6854548 RESEARCH - THE ALZHEIMER'S ASSOCIATION IS ON THE FOREFRONT OF THE ALZHEIMER'S SCIENTIFIC FIELD, GLOBALLY CONNECTING RESEARCHERS IN THE QUEST TO FIND METHODS OF TREATMENT, PREVENTION AND A CURE. THE ALZHEIMER'S ASSOCIATION IMPLEMENTS AN AGGRESSIVE GLOBAL RESEARCH AND SCIENCE PROGRAM STRATEGICALLY DESIGNED TO ACCELERATE PROGRESS BY FOSTERING INNOVATION, IDENTIFYING AND CLOSING CRITICAL KNOWLEDGE GAPS, DEVELOPING AND DISSEMINATING TOOLS, AND NURTURING SCIENTIFIC TALENT. THE ALZHEIMER'S ASSOCIATION HAS BEEN A CATALYST AND CONVENER FOR MORE THAN 30 YEARS. WHETHER FUNDING INNOVATIVE GRANTS TO HELP FURTHER TREATMENTS AND DISCOVERY, HOSTING THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE* (AAIC*), THE WORLD'S LARGEST GATHERING OF ALZHEIMER'S RESEARCHERS, OR LEADING ENDEAVORS LIKE THE WORLDWIDE ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE (WW-ADNI) TO ACCELERATE ADVANCES IN IMAGING, THE ALZHEIMER'S ASSOCIATION SEEKS TO FUND AND ADVANCE BEST-IN-CLASS RESEARCH AND WORKS WITH COLLABORATORS AROUND THE GLOBE FROM ALL SECTORS TO HASTEN THIS PROGRESS. * THESE ARE NAMES THAT ARE TRADEMARKS TO ALZHEIMER'S ASSOCIATION. 6905745 0 0 CHAPTER SERVICES - APPROXIMATELY 290 OFFICES ACROSS THE U.S. ARE DOING BUSINESS AS THE ALZHEIMER'S ASSOCIATION AND VARIOUS NAMES AS A COLLECTION OF 77 CHAPTERS OF THE ASSOCIATION AND ARE IN COMMUNITIES NATIONWIDE PROVIDING SERVICES TO FAMILIES AND PROFESSIONALS INCLUDING: INFORMATION AND REFERRAL, SUPPORT GROUPS, CARE CONSULTATION, AND EDUCATION AND SAFETY SERVICES. 20072381 7089342 2570 294847274 true false false true false false false false false true true true false false true true false true false false true true false true true true false true true true false false false false false false false true true false false false false true true true true false true 1447 3 true 2620 true true true false false false false true true false false false false false false X 28 28 false false false false false false false true true false true true true true true true true true true true false AL AK AZ CA CT DC FL GA IL KS KY ME MD MA MI MN MS NH NJ NM NY NC OK OR PA RI SC TX UT VA WA WV WI X X X RICHARD HOVLAND COOCFO 3123355771 225 N MICHIGAN AVE 17TH FLOOR Chicago IL 606017633 Alex Tsao Director (BEG. 10/18) 5.0 0.0 X 0 0 0 Anna Catalano SECRETARY AND DIRECTOR 10.0 0.0 X X 0 0 0 Brian Richardson Vice Chair and Director 12.0 0.0 X X 0 0 0 Bruce Baude Director 5.0 0.0 X 0 0 0 Carolyn Tieger Director 5.0 0.0 X 0 0 0 Cecile Perich DIRECTOR 5.0 0.0 X 0 0 0 Christopher Binkley Chair & Director (THRU 10/18) 12.0 0.5 X X 0 0 0 Cynthia Lemere Director (BEG. 10/18) 5.0 0.0 X 0 0 0 David Hunter Director 5.0 0.0 X 0 0 0 David Knopman MD Director (THRU 10/18) 5.0 0.0 X 0 0 0 David Goltermann Chair and Director 12.0 0.5 X X 0 0 0 Debra Pierson Director 5.0 0.0 X 0 0 0 Derek van Amerongen Director 5.0 0.0 X 0 0 0 Diana Kerwin MD Director 5.0 0.0 X 0 0 0 George Johnson Director (BEG. 10/18) 5.0 0.0 X 0 0 0 Helen Brooks Director 5.0 0.0 X 0 0 0 Jack Faer Director (THRU 10/18) 5.0 0.0 X 0 0 0 James Grossmann Director 5.0 0.0 X 0 0 0 John Tracy Director 5.0 0.0 X 0 0 0 Julia Wallace Director 5.0 0.0 X 0 0 0 Karen Stevenson Director 5.0 0.0 X 0 0 0 Karyne Jones Director (BEG. 10/18) 5.0 0.0 X 0 0 0 Kimberly Reed Director (THRU 10/18) 5.0 0.5 X 0 0 0 Louis Holland Jr Director (THRU 10/18) 5.0 0.0 X 0 0 0 Minoo Javanmardian Director 5.0 0.0 X 0 0 0 Pam Montana Director 5.0 0.0 X 0 0 0 Paul Wexler DIRECTOR 5.0 0.0 X 0 0 0 Paul Hornback Director (THRU 10/18) 5.0 0.0 X 0 0 0 Ralph Nixon MD PhD Director 5.0 0.0 X 0 0 0 Ryan Mundy Director (BEG. 10/18) 5.0 0.0 X 0 0 0 Sarah Lorance Director 5.0 0.0 X 0 0 0 Steven Osgood Treasurer and Director 10.0 0.0 X X 0 0 0 Thomas Doyle Director (BEG. 10/18) 5.0 0.0 X 0 0 0 William Thomas Director 5.0 0.0 X 0 0 0 HARRY JOHNS President & CEO 60.0 0.03 X 961690 767 52558 RICHARD HOVLAND COO/CFO & ASST. TREAS. 60.0 0.0 X 590206 0 60650 Christine Foh Asst Secy & VP Legal & GC 60.0 0.0 X 254370 0 39675 Maria Carrillo Chief Science Officer 60.0 0.0 X 596505 0 34671 ROBERT EGGE CHIEF PUBLIC POLICY OFFICER 60.0 1.65 X 565055 20238 64324 Donna McCullough Chief Development Officer 60.0 0.18 X 433863 2104 66454 KENANN CASSIDY EAST AREA LEADER 60.0 0.0 X 388841 0 44153 Glenda Berry WEST AREA LEADER 60.0 0.0 X 385280 0 52069 4175810 23109 414554 249 false true false Hayworth Marketing Media LLC 45 S 7th Street Suite 2400 MINNEAPOLIS MN 55402 ADVERTISING 11125488 World-Wide Printing Distrib Inc 2900 E Apache TULSA OK 74110 Direct Marketing 10848418 PERSONIFY INC 6500 River Place Blvd Bldg 3 Ste AUSTIN TX 78730 CRM DATABASE 2673137 MICHIGAN PLAZA LLC 205 N MICHIGAN AVE SUITE 810 CHICAGO IL 60601 OFFICE RENT 2580168 Softchoice Corporation 314 W Superior Suite 301 CHICAGO IL 60654 Technology/Equipment 2472818 204 571040 2158443 24365506 338462831 8031385 365557820 PROGRAM CONFERENCES 611710 6359633 6359633 SAFE RETURN REGISTRATION FEES 611710 483131 483131 CAREGIVER TRAINING 611710 309991 309991 JOURNAL 511120 192879 192879 REGISTRATION/EVENT REVENUE 900099 2173179 2173179 9518813 8199516 8199516 0 38303 38303 0 0 0 35897143 0 33875487 29671 2021656 -29671 1991985 1991985 7511884 2158443 3803891 3707993 3707993 20773 16798 3975 3975 242384 65705 176679 176679 GROUP CHAPTER REVENUE 900099 247444 247444 CHAPTER RENT ABATEMENT 900099 171073 171073 AFFILIATE REVENUE 900099 15030 15030 37247 37247 470794 389665878 9518813 14589245 36538217 36538217 1784337 1784337 14018323 14018323 0 2081356 609902 1180908 290546 0 140837768 105195475 5021597 30620696 22075560 16434051 836972 4804537 17375400 12801938 934935 3638527 60804 33930 17433 9441 0 428628 230953 155080 42595 155007 155007 596851 596851 1573775 1573775 203950 203950 23226382 17291110 2241457 3693815 26204339 21908638 23715 4271986 41134307 27637714 4085556 9411037 2182275 1581411 295706 305158 0 21374697 16011791 2470208 2892698 11294195 8040359 435551 2818285 0 16390874 10617436 280465 5492973 0 0 4460869 2890096 665220 905553 600447 328959 185256 86232 BAD DEBT EXPENSE 1441599 2397 288947 1150255 . 0 . 0 . 0 533913 293386 35028 205499 386573873 294847274 19512991 72213608 X 16419716 9799149 2657532 3963035 0 0 68055793 25013585 46695790 48565644 8496070 7722303 0 0 0 0 71218 0 1040794 801900 6136245 6926845 53145017 29922922 24721112 23222095 163106724 229875287 34892159 34689540 0 0 0 0 836154 827149 354052059 377644348 29835119 34975204 48509764 59855867 4775563 5474898 0 0 0 0 0 0 0 0 0 0 14726923 14514047 97847369 114820016 X 126389072 136816114 87419135 83684394 42396483 42323824 256204690 262824332 354052059 377644348 X 3092005 5573939 27704 -2074006 X false true X true true true X 149251302 158669271 301450526 321309088 365557820 1296238007 0 0 149251302 158669271 301450526 321309088 365557820 1296238007 0 1296238007 3055023 3039352 4882618 6355626 8237819 25570438 0 6633496 7077019 12716507 12152019 8245835 46824876 1368633321 40417092 0.94710 0.94239 X true true true 753000 true 2436 true true 7053868 true 2243406 true 1159000 false 11211710 false SCHEDULE C, PART II-B, LINE 1A VOLUNTEERS MOST OF THE ASSOCIATION'S ADVOCACY IS THROUGH VOLUNTEERS. ADDITIONALLY THE ASSOCIATION HAS TRAINING TO DEVELOP AND ORGANIZE CHAPTER BASED GRASSROOTS ACTIVITIES. AS ALZHEIMER'S DISEASE AND RELATED DEMENTIAS THREATEN TO BANKRUPT FAMILIES, BUSINESSES AND THE HEALTHCARE SYSTEM, SCIENTISTS ARE MOVING CLOSER TO FINDING BETTER TREATMENTS THAT COULD ALTER THE COURSE OF THE DISEASE. THE ALZHEIMER'S ASSOCIATION ADVOCATES FOR PUBLIC POLICIES AIMED AT ADVANCING RESEARCH TOWARD BETTER THERAPIES, DETECTION, METHODS OF PREVENTION AND ULTIMATELY A CURE, AS WELL AS FOR HIGH QUALITY HEALTHCARE AND LONG TERM SERVICES AND SUPPORT FOR PEOPLE WITH ALZHEIMER'S AND THEIR FAMILIES. THIS INCLUDES ADVOCACY FOR BETTER CARE FOR PEOPLE AND FAMILIES ALREADY FACING ALZHEIMER'S. ADVOCACY ACTIVITIES ALSO INCLUDE COLLABORATING WITH OTHER ORGANIZATIONS TO IMPROVE QUALITY CARE AND RAISE AWARENESS OF KEY ISSUES. SCHEDULE C, PART II-B, LINE 1B PAID STAFF OR MANAGEMENT THE ASSOCIATION HAS PAID STAFF WHO ENGAGE ON BEHALF OF THE ASSOCIATION IN PUBLIC POLICY WORK, INCLUDING EDUCATING POLICYMAKERS AND SUPPORTING THE ADVOCACY WORK OF VOLUNTEERS. SCHEDULE C, PART II-B, LINE 1C MEDIA ADVERTISEMENTS MEDIA ADVERTISEMENTS WERE RUN IN WASHINGTON, D.C. FOR KEY ADVOCACY AWARENESS OPPORTUNITIES DURING THE YEAR. SCHEDULE C, PART II-B, LINE 1D MAILING TO MEMBERS, LEGISLATORS OR THE PUBLIC MAILING COSTS TO DISTRIBUTE FACTS AND FIGURES TO LEGISLATORS. SCHEDULE C, PART II-B, LINE 1E PUBLICATIONS, OR PUBLISHED OR BROADCAST STATEMENTS THE ASSOCIATION DISTRIBUTED FEDERAL AND STATE UPDATES VIA EMAIL APPROXIMATELY 80 TIMES DURING THE YEAR. 24043831 208766 1557825 1557825 24252597 24038631 5200 894633 894633 24043831 13717133 10321498 1125281 1125281 24038631 13690883 26250 545968 545968 13717133 13715104 121524 537643 683388 13690883 0.97550 0.02450 false false 568500 568500 1323967 122292 1201675 12532077 5918471 6613606 10098080 7661316 2436764 28622393 16220843 12401550 23222095 BENEFICIAL INTEREST 34428502 F ASSETS HELD IN TRUST 261038 F 34689540 0 DEFERRED RENT 8693503 GIFT ANNUITY OBLIGATIONS 5820544 14514047 X 397906972 5573939 4675456 -2074006 8175389 389731583 -65705 -65705 389665878 391287330 4647752 65705 4713457 386573873 386573873 SCHEDULE D, PART V, LINE 4 INTENDED USES OF ENDOWMENT FUNDS A PORTION OF THE NET ASSETS WITH DONOR RESTRICTIONS ARE RESTRICTED AS INVESTMENTS IN PERPETUITY. THE ASSOCIATION'S ENDOWMENT ONLY CONSISTS OF DONOR-RESTRICTED ENDOWMENT FUNDS. NET ASSETS ASSOCIATED WITH THE ASSOCIATION'S ENDOWMENT FUNDS ARE CLASSIFIED AND REPORTED BASED ON THE EXISTENCE OF DONOR-IMPOSED RESTRICTIONS. DONORS RESTRICT THE EARNINGS OF SOME OF THE ASSOCIATIONS ENDOWMENT FUNDS TO FUND THE ASSOCIATION'S RESEARCH PROGRAM. IN ACCORDANCE WITH DONOR STIPULATIONS, THE INCOME GENERATED FROM THESE ASSETS IS RESTRICTED FOR RESEARCH (APPROXIMATELY 57%) OR NOT PURPOSE RESTRICTED (APPROXIMATELY 43%). THE ASSOCIATION ACCOUNTS FOR ENDOWMENT NET ASSETS BY PRESERVING THE FAIR VALUE OF THE ORIGINAL GIFT AS OF THE GIFT DATE OF THE DONOR-RESTRICTED ENDOWMENT FUND ABSENT EXPLICIT DONOR STIPULATIONS TO THE CONTRARY. AS A RESULT, THE ASSOCIATION CLASSIFIES AS PERMANENTLY RESTRICTED NET ASSETS (1) THE ORIGINAL VALUE OF GIFTS DONATED TO THE PERMANENT ENDOWMENT, (2) THE ORIGINAL VALUE OF SUBSEQUENT GIFTS TO THE PERMANENT ENDOWMENT AND (3) ACCUMULATIONS TO THE PERMANENT ENDOWMENT MADE IN ACCORDANCE WITH THE DIRECTION OF THE APPLICABLE DONOR GIFT INSTRUMENT AT THE TIME THE ACCUMULATION IS ADDED TO THE ENDOWMENT FUND. THE ASSOCIATION CONSIDERS THE FOLLOWING FACTORS IN MAKING A DETERMINATION TO APPROPRIATE OR ACCUMULATE DONOR-RESTRICTED ENDOWMENT FUNDS: -THE DURATION AND PRESERVATION OF THE FUND. -THE PURPOSES OF THE ASSOCIATION AND THE DONOR-RESTRICTED ENDOWMENT FUND. -GENERAL ECONOMIC CONDITIONS. -THE POSSIBLE EFFECTS OF INFLATION AND DEFLATION. -THE EXPECTED TOTAL RETURN FROM INCOME AND THE APPRECIATION OF INVESTMENTS. -OTHER RESOURCES OF THE ASSOCIATION. -THE INVESTMENT POLICIES OF THE ASSOCIATION. THE ASSOCIATION HAS ADOPTED AN INVESTMENT POLICY THAT ATTEMPTS TO PROVIDE A PREDICTABLE STREAM OF FUNDING TO PROGRAMS SUPPORTED BY ITS ENDOWMENT WHILE SEEKING TO MAINTAIN THE PURCHASING POWER OF THE ENDOWMENT ASSETS. AS OF JUNE 30, 2019 AND 2018, ENDOWMENT ASSETS ONLY INCLUDE THOSE ASSETS OF DONOR-RESTRICTED FUNDS THAT THE ASSOCIATION MUST HOLD IN PERPETUITY, AS THE ASSOCIATION DOES NOT HAVE ANY BOARD-DESIGNATED ENDOWMENT FUNDS. UNDER THIS POLICY, AS APPROVED BY THE BOARD OF DIRECTORS, THE ENDOWMENT ASSETS ARE INVESTED IN A MANNER THAT IS INTENDED TO PROVIDE ADEQUATE LIQUIDITY, MAXIMIZING RETURNS ON ALL FUNDS INVESTED AND ACHIEVING FULL EMPLOYMENT OF ALL AVAILABLE FUNDS AS EARNING ASSETS. THE ASSOCIATION HAS AN ACTIVE FINANCE COMMITTEE AND INVESTMENT SUB-COMMITTEE THAT MEETS REGULARLY TO ENSURE THAT THE OBJECTIVES OF THE INVESTMENT POLICY ARE MET, AND THAT THE STRATEGIES USED TO MEET THE OBJECTIVES ARE IN ACCORDANCE WITH THE INVESTMENT POLICY. THE ASSOCIATION'S POLICY IS TO APPROPRIATE SPENDING AMOUNTS DEEMED PRUDENT FOR DONOR-RESTRICTED FUNDS. SCHEDULE D, PART X, LINE 2 FIN 48 THE ASSOCIATION AND Alzheimer's Impact Movement (AIM) HAVE RECEIVED FAVORABLE DETERMINATION LETTERS FROM THE INTERNAL REVENUE SERVICE, STATING THAT THEY ARE EXEMPT FROM FEDERAL INCOME TAXES UNDER THE PROVISIONS OF SECTION 501(A) OF THE INTERNAL REVENUE CODE OF 1986 (IRC), AS ORGANIZATIONS DESCRIBED IN SECTIONS 501(C)(3) AND 501(C)(4), RESPECTIVELY, EXCEPT FOR INCOME TAXES PERTAINING TO UNRELATED BUSINESS INCOME. Alzheimer's Impact Movement Political Action Committee (AIMPAC) IS A POLITICAL ACTION COMMITTEE ORGANIZATION EXEMPT FROM FEDERAL TAXES UNDER SECTION 527 OF THE IRC. THE ALZHEIMER'S ASSOCIATION INTERNATIONAL IS A NOT-FOR-PROFIT CANADIAN ENTITY. THE COALITION of New York State Alzheimer's Association Chapters, Inc. IS A NOT-FOR-PROFIT ORGANIZATION EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) OF THE IRC AND HAS NOT BEEN CLASSIFIED AS A PRIVATE FOUNDATION; THEREFORE, NO PROVISION FOR INCOME TAX HAS BEEN MADE IN THE FINANCIAL STATEMENTS. THE FINANCIAL ACCOUNTING STANDARDS BOARD (FASB) ISSUED GUIDANCE THAT REQUIRES TAX EFFECTS FROM UNCERTAIN TAX POSITIONS TO BE RECOGNIZED IN THE CONSOLIDATED FINANCIAL STATEMENTS ONLY IF THE POSITION IS MORE LIKELY THAN NOT TO BE SUSTAINED IF THE POSITION WERE TO BE CHALLENGED BY A TAXING AUTHORITY. MANAGEMENT HAS DETERMINED THERE ARE NO MATERIAL UNCERTAIN POSITIONS THAT REQUIRE RECOGNITION IN THE CONSOLIDATED FINANCIAL STATEMENTS AND, AS SUCH, NO PROVISION FOR INCOME TAXES IS REFLECTED. ADDITIONALLY, THERE ARE NO INTEREST OR PENALTIES RECOGNIZED IN THE CONSOLIDATED STATEMENT OF ACTIVITIES OR STATEMENT OF FINANCIAL POSITION. Schedule D, Part XI, Line 2D RECONCILIATION OF REVENUE CHANGE IN PERPETUAL TRUST ($281,426) CHANGE IN SPLIT INTEREST ($1,792,580) -------------- TOTAL ($2,074,006) SCHEDULE D, PART XI, LINE 4B RECONCILIATION OF REVENUE COST OF GOODS SOLD ($65,705) ---------- TOTAL ($65,705) SCHEDULE D, PART XII, LINE 2D RECONCILIATION OF EXPENSES COST OF GOODS SOLD $65,705 ---------- TOTAL $65,705 true Europe (Including Iceland and Greenland) Program Services Grantmaking 11648745 East Asia and the Pacific Program Services Grantmaking 1195266 North America Program Services Grantmaking 999349 South America Program Services Grantmaking 174963 14018323 14018323 East Asia and the Pacific Program Support 149400 Wire 0 East Asia and the Pacific Program Support 28125 Wire 0 East Asia and the Pacific Program Support 149975 Wire 0 East Asia and the Pacific Program Support 747766 Wire 0 Europe Program Support 150000 Wire 0 Europe Program Support 174990 Wire 0 Europe Program Support 175000 Wire 0 South America Program Support 150000 Wire 0 South America Program Support 24963 Wire 0 North America Program Support 749482 Wire 0 North America Program Support 150000 Wire 0 Europe Program Support 369980 Wire 0 Europe Program Support 150000 Wire 0 Europe Program Support 749996 Wire 0 Europe Program Support 24578 Wire 0 Europe Program Support 24967 Wire 0 Europe Program Support 24975 Wire 0 Europe Program Support 150000 Wire 0 Europe Program Support 150000 Wire 0 Europe Program Support 25000 Wire 0 Europe Program Support 25000 Wire 0 Europe Program Support 748440 Wire 0 North America Program Support 25000 Wire 0 North America Program Support 25000 Wire 0 Europe Program Support 24706 Wire 0 Europe Program Support 150000 Wire 0 Europe Program Support 150000 Wire 0 Europe Program Support 146207 Wire 0 East Asia and the Pacific Program Support 120000 Wire 0 Europe Program Support 142998 Wire 0 Europe Program Support 149160 Wire 0 Europe Program Support 173826 Wire 0 Europe Program Support 149722 Wire 0 Europe Program Support 80000 Wire 0 Europe Program Support 25000 Wire 0 Europe Program Support 7337810 Wire 0 Europe Program Support 119902 Wire 0 North America Program Support 49867 Wire 0 Europe Program Support 50000 Wire 0 Europe Program Support 6488 Wire 0 40 false false true false false false Schedule F, Part I, Line 2 PROCEDURE FOR MONITORING USE OF GRANT FUNDS OUTSIDE U.S. The over-sight of the scientific integrity of the Alzheimer's Association National and International Research Grant Program is three-fold. First, the Alzheimer's Association voluntary Medical & Scientific Advisory Group (MSAG), the Alzheimers Association International Research Grant Program (IRGP) Council, and Alzheimer's Association Medical & Scientific Relations division, ensures peer review and high quality of funded awards during the grant review process and develops focused requests for applications (RFAs) based on identified needs in the Alzheimers and all dementia research community. Second, the Alzheimer's Association is engaged in a portfolio analysis of scientific areas of investment to monitor the diversity of the grants portfolio, potential gaps in research funding, and potential overlap of areas funded. The analysis informs future funding decisions, strategic activities and areas of future-RFA focus. Third, there is a detailed process once a grant is awarded to monitor program and scientific and financial integrity. The Alzheimer's Association monitors the use of grant funds both inside and outside of the United States as follows: All awardees are required to provide annual and in some cases bi-annual reporting to the Alzheimer's Association on both the status of the research project and financial expenditures associated with the project. Several programs are leveraged funding opportunities with partner organizations. These research projects and financial expenditure reports are shared between the partner organization(s). Sixty days prior to the anniversary of the award start date, an Alzheimer's Association Post-Award Specialist notifies all researchers and all designated institutional financial officials with fiscal responsibility for the award of the required reports, which include an interim scientific report, interim financial report, documentation of any publications as a result of Association funding, and annual verification of required ethical (animal and human) approvals. The institutional official who has fiscal responsibility for the award cannot be the primary investigator of the project. The Alzheimer's Association provides a template for the interim scientific report and a template for the interim financial report, both of which are available for download by the researchers as well as the official with fiscal responsibility for the grant at the awarded institution at https://proposalcentral.com. The financial report must be signed by the institutional official with fiscal responsibility, and all reports must be uploaded by the award recipient to proposalCENTRAL. After receipt, all financial reports are reviewed by an Alzheimer's Association Post-Award Specialist for accuracy and consistency with the agreed upon budget. In addition, the Association requires protocol continuation approval (i.e., INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC), INSTITUTIONAL ETHICAL REVIEW BOARD (IRB), RECOMBINANT DNA PROTOCOL (RDNA)) annually, if applicable for the research project. Any subsequent payments to grant awardees are generated after the receipt of these documents and approval by the Chief Science Officer, Medical and Scientific Relations. At the conclusion of the award, all reports/publication(s) are due 90 days after the award expires and must be uploaded to the proposalCENTRAL online system. The financial report must be signed by the institutional official who has fiscal responsibility for the award. Publication(s) as accepted are uploaded to proposalCENTRAL during and after the duration of the grant. It is expected that awardees will continue to maintain record of any publication(s) acknowledging the Alzheimer's Association. Data generated as a result of Alzheimer's Association funded work is subject to data sharing, as a condition of award. Data and other outputs of the project are subjected to this policy for quick, reasonable submissions for completed work. Further, Awardees agree to submit/share data, as applicable, through the Global Alzheimer's Association Interactive Network (GAAIN*), a global infrastructure connecting research studies from around the world through one portal where data can be interrogated in aggregate for analysis using a virtual machine. GAAIN is wholly funded by the Alzheimer's Association. In addition, the Association requests, monitors, and follows-up to ensure submission compliance on all awarded grants and that financial reporting requirements are met. Awardees' financial reports are reviewed annually to ensure eligibility for continued funding. Delinquent report(s) may result in the withdrawal of funding. Researchers are informed that delinquent reporting could lead to withdrawal of funding when the request for annual report(s) is sent. If funding is withdrawn due to delinquent reports, any unspent funds must be returned to the Alzheimer's Association. Foreign Institutions are required to submit one of the following as verification of Non-Profit status: - Organization's charter, bylaws and other governing documents (In english, if possible). In cases where translation is not possible, a dated and signed letter in english from the rector or other authorized signing official of the institution is acceptable. - Documentation of non-profit designation from organization's government. For-profit organizations are not eligible to apply to the Alzheimer's Association's International Research Grant Program, with the exception of the Part the Cloud Translational Research Grant Program, Alzheimers Innovation Award and certain partnership programs, including Biomarkers Across Neurodegenerative Diseases (BAND) and Tau Pipeline Enabling Program (T-PEP). Eligibility of organizations applicable for a program are detailed in that program's RFA. Unless otherwise stated in program, all institutions are required to submit verification of their non-profit status dated within the last five years (e.g., IRS tax determination letter). If the IRS determination letter is dated prior to this five year period, the institution is required to provide documentation from an authorized signing official in their Grants and Contracts Office or Office of Sponsored Research to confirm there has not been a status change for the organization. For the Part the Cloud Translational Research Grant Program and other programs with for-profit awardees, any for-profit applicant is required to submit the Organization's financial statements. As part of the application process, applicants are to upload a W-8BEN-E form that has been dated and signed by an authorized signing official. This form verifies that an institution or organization is designated as a 501(c)(3) or other non-profit entity. For profit organizations must submit documentation of net assets and annual earnings, in addition to the W-8BEN-E form for consideration. These forms are uploaded within their submitted application to proposalCENTRAL. After receipt, these forms are reviewed by an Alzheimer's Association pre-award specialist. Following review by a pre-award specialist, applications are then moved forward to peer-review. If awarded, the Alzheimer's Association post-award specialist includes the appropriate forms in payment requests for grant funding payments. Prior to award confirmation, the Medical and Scientific Relations Division verifies that each Institution is compliant with the U.S. Patriot Act and does not appear on the Specially Designated Nationals (SDN) lists. Prior to payment, each funded Alzheimers Association grant awardee (i.e. the institution) is verified for compliance with the U.S. Patriot Act. The Post Award Specialist confirms eligibility and provides this documentation to the grant online file at proposalCENTRAL prior to payment being sent to the Awardee. In the event that a positive match to one of the SDN lists is found by the Association, it will be immediately reported to the Alzheimers Association legal department for appropriate handling and follow-up. For transactions unrelated to the International Research Grant Program in the Medical and Scientific Department, the same financial documentation is reviewed. The Alzheimer's Association monitors the scientific advances of the Association's grant awardees by maintaining records of publications, presentations, and intellectual property that result from funded studies. The Association requires the grant recipient to notify the Alzheimer's Association on an annual basis with updates to these records. Follow-on funding from federal agencies is also monitored. * These are names that are trademarks to Alzheimer's Association. Schedule F, Part I, Line 3, Column (f) and Part II, Line 1 Method Used to Account for Expenditures and Grants The Alzheimer's Association accounts for expenditures, cash grants, and noncash assistance using the accrual method. X X X X X X X true THD 80 Hayden Avenue Ste 300 Lexington MA 02421 Mail false 39968259 1330375 38637884 CDR 16900 Science Drive Suite 210 Bowie MD 20715 Email false 20871952 243400 20628552 60840211 1573775 59266436 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY Chicago Gala 686250 47600 638650 0 127041 18619 348162 0 0 New York Gala 560000 84150 475850 0 151108 72064 45340 163595 0 35 8424077 2026693 6397384 0 1080209 361674 1119020 112741 204318 9670327 2158443 7511884 0 1358358 452357 1512522 276336 204318 3803891 3707993 20773 3976 12822 false 20773 3976 12822 16798 3975 IL IA MN NE NY OH true false true false Michelle Helton 225 N Michigan Ave 17th Flr Chicago IL 606017633 false Lynne Carey 544 Overall supervision and management X false Schedule G, Part I, Line 2B, Box (III) FUNDRAISING CONSULTANT - CONTROL ARRANGEMENT The Alzheimer's association engages Thompson, Habib & Denison INC. (THD) for professional fundraising consultant services. A description of the arrangement is listed below: Direct marketing strategy and program direction; production management; database management; budgeting management; and report management. The Alzheimer's Association engages Creative Direct Response, Inc. (CDR) for professional fundraising digital marketing consultant services. A description of the arrangement is listed below: Digital Marketing strategy and program direction; E-Mail program management; production management; database management; and budgeting management. Schedule G, Part I, Line 2B, Box (VI) FUNDRAISING CONSULTANT - FEE ARRANGEMENT The agreement between Thompson, Habib & Denison (THD) and the Alzheimer's Association is not a percentage-based agreement. THD is paid a fixed fee per month. The Alzheimer's Association exercises control and approval over the content and frequency of all solicitations. The agreement between Creative Direct Response, Inc. (CDR) and the Alzheimer's Association is not a Percentage-Based Agreement. CDR is paid a fixed fee per month. The Alzheimer's Association exercises control and approval. Schedule G, Part III, Line 16 GAMING MANAGER INFORMATION Alzheimer's association has more gaming managers than lynne carey listed on part iii, line 16. This information is available upon request from alzheimer's home office. true Albert Einstein College of Medicine 1300 Morris Park Avenue Bronx NY 10461 472209056 501(C)(3) 170000 0 Program Support American College of Radiology 1891 Preston White Drive Reston VA 20191 362216602 501(C)(3) 200000 0 Program Support Banner Alzheimer's Foundation 2901 N Central Avenue Phoenix AZ 85012 204862361 501(C)(3) 750000 0 Program Support Baylor College of Medicine 1 Baylor Plaza MSBCM 310 Houston TX 77030 741613878 501(C)(3) 450000 0 Program Support Baylor Research Institute 2001 Bryan St Suite 2200 Dallas TX 75201 751921898 501(C)(3) 106702 0 Program Support Beth Israel Deaconess Medical Center 330 Brookline Ave Boston MA 02215 042103881 501(C)(3) 175000 0 Program Support Beth Israel Deaconess Medical Center 330 Brookline Ave Boston MA 02215 042103881 501(C)(3) 174600 0 Program Support BUCK INSTITUTE FOR RESEARCH ON AGING 8001 Redwood Blvd Novato CA 94945 943030609 501(C)(3) 175000 0 Program Support Case Western Reserve University 10900 Euclid Avenue Cleveland OH 44106 341018992 501(C)(3) 149729 0 Program Support Columbia University Medical Center 630 W 168th St Box 49 New York NY 10032 135598093 501(C)(3) 175000 0 Program Support Columbia University Medical Center 630 W 168th St Box 49 New York NY 10032 135598093 501(C)(3) 174880 0 Program Support Columbia University Medical Center 630 W 168th St Box 49 New York NY 10032 135598093 501(C)(3) 150000 0 Program Support Duke University Medical Center 2200 W Main St Ste 820 Durham NC 27705 560532129 501(C)(3) 150000 0 Program Support Eikonizo Therapeutics Inc 700 Main Street Cambridge MA 02139 823062283 501(C)(3) 150000 0 Program Support Emory University 1599 Clifton RdNE4th Fl Atlanta GA 30322 580566256 501(C)(3) 175000 0 Program Support Emory University 1599 Clifton RdNE4th Fl Atlanta GA 30322 580566256 501(C)(3) 147278 0 Program Support Emory University 1599 Clifton RdNE4th Fl Atlanta GA 30322 580566256 501(C)(3) 150000 0 Program Support Florida Atlantic University 777 Glades Road Boca Raton FL 33431 650385507 501(C)(3) 150000 0 Program Support Found for the Nat'l Institute of Health 9650 Rockville Pike Bethesda MD 20814 521986675 501(C)(3) 75000 0 Program Support Found for the Nat'l Institute of Health 9650 Rockville Pike Bethesda MD 20814 521986675 501(C)(3) 121000 0 Program Support Found for the Nat'l Institute of Health 9650 Rockville Pike Bethesda MD 20814 521986675 501(C)(3) 200000 0 Program Support Georgetown University 4000 Reservoir Rd NW Washington DC 20007 530196603 501(C)(3) 750000 0 Program Support Georgia Institute of Technology North Ave NW Atlanta GA 30332 580603146 501(C)(3) 149844 0 Program Support Global Brain Health Institute 675 Nelson Rising San Francisco CA 94158 946036493 501(C)(3) 24999 0 Program Support Global Brain Health Institute 675 Nelson Rising San Francisco CA 94158 946036493 501(C)(3) 25000 0 Program Support Global Brain Health Institute 675 Nelson Rising San Francisco CA 94158 946036493 501(C)(3) 24956 0 Program Support Hebrew Rehabilitation Center 1200 Centre Street Boston MA 02131 042104298 501(C)(3) 139991 0 Program Support High Point University One University Parkway High Point NC 27268 560529999 501(C)(3) 149997 0 Program Support Indiana University 509 E 3rd Street Bloomington IN 47401 356001673 501(C)(3) 999756 0 Program Support Indiana University 509 E 3rd Street Bloomington IN 47401 356001673 501(C)(3) 174990 0 Program Support Indiana University 509 E 3rd Street Bloomington IN 47401 356001673 501(C)(3) 174957 0 Program Support Kaiser Foundation Research Institute 1800 Harrison St 16th Fl Oakland CA 94612 941105628 501(C)(3) 149992 0 Program Support Longeveron LLC 1951 NW 7th Ave Ste 520 Miami FL 33136 472174146 N/A 3000000 0 Program Support Massachusetts General Hospital 55 Fruit Street Boston MA 02114 042697983 501(C)(3) 15000 0 Program Support Massachusetts General Hospital 55 Fruit Street Boston MA 02114 042697983 501(C)(3) 96250 0 Program Support Massachusetts General Hospital 55 Fruit Street Boston MA 02114 042697983 501(C)(3) 96250 0 Program Support Massachusetts General Hospital 55 Fruit Street Boston MA 02114 042697983 501(C)(3) 96250 0 Program Support Massachusetts General Hospital 55 Fruit Street Boston MA 02114 042697983 501(C)(3) 174998 0 Program Support Massachusetts General Hospital 55 Fruit Street Boston MA 02114 042697983 501(C)(3) 150000 0 Program Support Massachusetts General Hospital 55 Fruit Street Boston MA 02114 042697983 501(C)(3) 150000 0 Program Support Massachusetts Institute of Technology 77 Massachusetts Avenue Cambridge MA 02139 042103594 501(C)(3) 140000 0 Program Support Massachusetts Institute of Technology 77 Massachusetts Avenue Cambridge MA 02139 042103594 501(C)(3) 140000 0 Program Support Mayo Clinic Jacksonville 4500 San Pablo Road Jacksonville FL 32224 593337028 501(C)(3) 150000 0 Program Support McLean Hospital 115 Mill Street Belmont MA 02478 042697981 501(C)(3) 170000 0 Program Support New York University School of Medicine One Park Ave 6th Fl New York NY 10016 135562308 501(C)(3) 175000 0 Program Support North Carolina State University 2701 Sullivan Dr Ste240 Raleigh NC 27695 566000756 501(C)(3) 150000 0 Program Support President and Fellows of Harvard College 677 Huntington Avenue Boston MA 02115 042103580 501(C)(3) 139977 0 Program Support University of Minnesota - Twin Cities 200 Oak Street SE Minneapolis MN 55455 416007513 501(C)(3) 53000 0 Program Support Rush University Medical Center 1653 W Congress Parkway Chicago IL 60612 362174823 501(C)(3) 517925 0 Program Support Stanford University 3172 Porter Drive Palo Alto CA 94303 941156365 501(C)(3) 175000 0 Program Support Stanford University 3172 Porter Drive Palo Alto CA 94304 941156365 501(C)(3) 149999 0 Program Support University of IL at Urbana-Champaign 1901 South 1st StSte A Champaign IL 61820 376000511 501(C)(3) 150000 0 Program Support The University of Virginia PO Box 400195 Charlottesville VA 22904 546001796 501(C)(3) 175000 0 Program Support The Regents of the Univ of CA Davis 1850 Research Park Drive Davis CA 95618 946036494 501(C)(3) 150000 0 Program Support The Regents of the Univ of CA Davis 1850 Research Park Drive Davis CA 95618 946036494 501(C)(3) 297898 0 Program Support The Regents of the Univ of CA Davis 1850 Research Park Drive Davis CA 95618 946036494 501(C)(3) 20000 0 Program Support The Regents of the Univ of CA Irvine 141 Innovation Suite 250 Irvine CA 92697 952226406 501(C)(3) 150000 0 Program Support The Reg of the Univ of CA San Diego 9500 Gilman DrDept 0934 La Jolla CA 92093 956006144 501(C)(3) 25000 0 Program Support The Reg of the Univ of CA San Diego 9500 Gilman DrDept 0934 La Jolla CA 92093 956006144 501(C)(3) 25000 0 Program Support University of California San Francisco 3333 Ca St Ste 315 San Francisco CA 94118 946036493 501(C)(3) 140000 0 Program Support University of California San Francisco 3333 Ca St Ste 315 San Francisco CA 94118 946036493 501(C)(3) 175000 0 Program Support University of California San Francisco 3333 Ca St Ste 315 San Francisco CA 94118 946036493 501(C)(3) 25000 0 Program Support University of California San Francisco 3333 Ca St Ste 315 San Francisco CA 94118 946036493 501(C)(3) 25000 0 Program Support University of California San Francisco 3333 Ca St Ste 315 San Francisco CA 94118 946036493 501(C)(3) 218493 0 Program Support University of California San Francisco 3333 Ca St Ste 315 San Francisco CA 94118 946036493 501(C)(3) 10000 0 Program Support University of California San Francisco 3333 Ca St Ste 315 San Francisco CA 94118 946036493 501(C)(3) 10000 0 Program Support The Reg of the University of Michigan 3003 S State Street Ann Arbor MI 48109 386006309 501(C)(3) 140000 0 Program Support The Reg of the University of Michigan 3003 S State Street Ann Arbor MI 48109 386006309 501(C)(3) 149996 0 Program Support The Research Foundation of SUNY 450 Clarkson AveBox 129 Brooklyn NY 11203 141368361 501(C)(3) 25000 0 Program Support The Salk Inst for Biological Studies 10010 N Torrey Pines Rd LaJolla CA 92037 952160097 501(C)(3) 175000 0 Program Support The Salk Inst for Biological Studies 10010 N Torrey Pines Rd LaJolla CA 92037 952160097 501(C)(3) 175000 0 Program Support The Trustees of the Univ of PENN 3451 Walnut Street Philadelphia PA 19104 231352685 501(C)(3) 50000 0 Program Support The Trustees of the Univ of PENN 3451 Walnut Street Philadelphia PA 19104 231352685 501(C)(3) 139497 0 Program Support The Trustees of the Univ of PENN 3451 Walnut Street Philadelphia PA 19104 231352685 501(C)(3) 175000 0 Program Support The Trustees of the Univ of PENN 3451 Walnut Street Philadelphia PA 19104 231352685 501(C)(3) 175000 0 Program Support The Trustees of the Univ of PENN 3451 Walnut Street Philadelphia PA 19104 231352685 501(C)(3) 139268 0 Program Support The Trustees of the Univ of PENN 3451 Walnut Street Philadelphia PA 19104 231352685 501(C)(3) 174958 0 Program Support The University of Chicago 6054 SDrexel AveSte300 Chicago IL 60637 362177139 501(C)(3) 175000 0 Program Support The University of Iowa 2 Gilmore Hall Iowa City IA 52242 426004813 501(C)(3) 150000 0 Program Support The Univ of TX Health Science Center 7000 Fannin UCT 1006 Houston TX 77030 741761309 501(C)(3) 175000 0 Program Support The Univ of TX Health Science Center 7000 Fannin UCT 1006 Houston TX 77030 741761309 501(C)(3) 149997 0 Program Support The Univ of TX Health Science Center 7000 Fannin UCT 1006 Houston TX 77030 741761309 501(C)(3) 450000 0 Program Support The Univ of TX Med Branch at Galveston 301 University Blvd Galveston TX 77555 746000949 501(C)(3) 150000 0 Program Support Univ of Texas Health Science Center 7703 Floyd Curl Drive San Antonio TX 78229 741586031 501(C)(3) 148900 0 Program Support University of Colorado at Boulder 1800 Grant St Ste 600 Denver CO 80309 846000555 501(C)(3) 10000 0 Program Support University of Connecticut 438 Whitney Rd Unit 1133 Storrs CT 06269 060772160 501(C)(3) 150000 0 Program Support University of Connecticut Health Center 263 Farmington Avenue Farmington CT 06030 521725543 501(C)(3) 171963 0 Program Support University of Florida 207 Grinter Hall Gainesville FL 32611 596002052 501(C)(3) 140000 0 Program Support University of Houston 4302 University Drive Houston TX 77204 746001399 501(C)(3) 150000 0 Program Support University of Illinois at Chicago 809 S Marshfield Avenue Chicago IL 60612 376000511 501(C)(3) 119825 0 Program Support Univ of Massachusetts Medical School 55 Lake Avenue North Worcester MA 01655 043167352 501(C)(3) 148272 0 Program Support UNIVERSITY OF MIAMI 1320 SoDixie Hgway Coral Gables FL 33146 590624458 501(C)(3) 449532 0 Program Support Univ of North TX Health Science Center 3500 Camp Bowie Blvd Fort Worth TX 76107 756064033 501(C)(3) 149616 0 Program Support University of Pittsburgh 123 University Place Pittsburgh PA 15213 250965591 501(C)(3) 10000 0 Program Support University of Pittsburgh 123 University Place Pittsburgh PA 15213 250965591 501(C)(3) 10000 0 Program Support University of Pittsburgh 123 University Place Pittsburgh PA 15213 250965591 501(C)(3) 150000 0 Program Support University of Pittsburgh 123 University Place Pittsburgh PA 15213 250965591 501(C)(3) 227268 0 Program Support University of Pittsburgh 123 University Place Pittsburgh PA 15213 250965591 501(C)(3) 175000 0 Program Support University of Rochester 518 Hylan Bld Bx 270140 Rochester NY 14627 160743209 501(C)(3) 150000 0 Program Support University of South Florida 4019 E Fowler Ave Ste 100 Tampa FL 33617 593102112 501(C)(3) 25000 0 Program Support University of South Florida 4019 E Fowler Ave Ste 100 Tampa FL 33617 593102112 501(C)(3) 175000 0 Program Support University of South Florida 4019 E Fowler Ave Ste 100 Tampa FL 33617 593102112 501(C)(3) 150000 0 Program Support University of Southern California 837 W Downey Way Los Angeles CA 90089 951642394 501(C)(3) 457000 0 Program Support University of Southern California 837 W Downey Way Los Angeles CA 90089 951642394 501(C)(3) 503592 0 Program Support University of Southern California 837 W Downey Way Los Angeles CA 90089 951642394 501(C)(3) 186531 0 Program Support University of Southern California 837 W Downey Way Los Angeles CA 90089 951642394 501(C)(3) 113469 0 Program Support University of Washington 4333 Brooklyn Box 359472 SEATTLE WA 98195 916001537 501(C)(3) 24848 0 Program Support University of Wisconsin-Madison 21 North Park Ste 6401 Madison WI 53715 396006492 501(C)(3) 172600 0 Program Support University of Wisconsin-Madison 21 North Park Ste 6401 Madison WI 53715 396006492 501(C)(3) 174788 0 Program Support University of California Berkeley 2150 Shattuck AveSte313 Berkeley CA 94704 946002123 501(C)(3) 373650 0 Program Support University of Southern California 3720 Flower St 3rdFl Los Angeles CA 90089 951642394 501(C)(3) 100000 0 Program Support UT Southwestern Medical Center 5323 Harry Hines Blvd Dallas TX 75390 175600286 501(C)(3) 148836 0 Program Support Wake Forest University Health Sciences Medical Ctr Blvd WinstonSalem NC 27157 223849199 501(C)(3) 440560 0 Program Support Wake Forest University Health Sciences Medical Ctr Blvd WinstonSalem NC 27157 223849199 501(C)(3) 175000 0 Program Support Wake Forest University Health Sciences Medical Ctr Blvd WinstonSalem NC 27157 223849199 501(C)(3) 1803936 0 Program Support Wake Forest University Health Sciences Medical Ctr Blvd WinstonSalem NC 27157 223849199 501(C)(3) 1154900 0 Program Support Washington University in St Louis One Brooking Drive St Louis MO 63130 430653611 501(C)(3) 780689 0 Program Support Washington University in St Louis One Brooking Drive St Louis MO 63130 430653611 501(C)(3) 505349 0 Program Support Washington University in St Louis One Brooking Drive St Louis MO 63130 430653611 501(C)(3) 142242 0 Program Support Washington University in StLouis One Brooking Drive St Louis MO 63130 430653611 501(C)(3) 149375 0 Program Support Washington University in StLouis One Brooking Drive St Louis MO 63130 430653611 501(C)(3) 140000 0 Program Support Alzheimer's Impact Movement 225 North Michigan Avenue Chicago IL 60601 271961435 501(C)(4) 7053868 0 Public Policy Massachusetts General Hospital 55 Fruit Street Boston MA 02114 042697983 501(C)(3) 140000 0 Program Support Banner Alzheimer's Foundation 2901 N Central Ave Phoenix AZ 85012 204862361 501(C)(3) 750000 0 Program Support SOUTH CAROLINA DEPARTMENT ON AGING 1301 Gervais St STE 200 Columbia SC 29201 576000286 501(C)(3) 900000 PROGRAM SUPPORT CITY OF LAUDERDALE LAKES 4320 NW 36th St Fort LAUDERDALE FL 33319 590974050 501(c)(3) 30000 PROGRAM SUPPORT 124 2 Schedule I, Part I, Line 2 PROCEDURE FOR MONITORING USE OF GRANT FUNDS INSIDE U.S. The over-sight of the scientific integrity of the Alzheimer's Association National and International Research Grant Program is three-fold. First, the Alzheimer's Association voluntary Medical & Scientific Advisory Group (MSAG), the Alzheimers Association International Research Grant Program Council, and the Alzheimer's Association Medical & Scientific Relations division, ensures peer review and high quality of funded awards during the grant review process and develops focused requests for applications (RFAs) based on identified needs in the Alzheimer research community. Second, the Alzheimer's Association is engaged in a portfolio analysis of scientific areas of investment to monitor the diversity of the grants portfolio, potential gaps in research funding, and potential overlap of areas funded. The analysis informs future funding decisions, strategic activities and areas of future RFA focus. Third, there is a detailed process once a grant is awarded to monitor program and scientific and financial integrity. The Alzheimer's Association monitors the use of grant funds both inside and outside of the United States as follows: All awardees are required to provide annual and in some cases bi-annual reporting to the Alzheimer's Association on both the status of the research project and financial expenditures associated with the award. Several programs are leveraged funding opportunities with partner organizations. These research projects and financial expenditure reports are shared between the partner organization(s). Sixty days prior to the anniversary of the award start date, an Alzheimer's Association Post-Award Specialist notifies all researchers and all designated institutional financial officials with fiscal responsibility for the award of the required reports, which include an interim scientific report, interim financial report, documentation of any publications as a result of Association funding, and annual verification of required ethical (animal and human) approvals. The institutional official who has fiscal responsibility for the award cannot be the primary investigator of the project. The Alzheimer's Association provides a template for the interim scientific report and a template for the interim financial report, both of which are available for download by the researchers as well as the official with fiscal responsibility for the grant at the awarded institution at https://proposalcentral.com/. The financial report must be signed by the institutional official with fiscal responsibility, and all reports must be uploaded by the award recipient to proposalCENTRAL. After receipt, all financial reports are reviewed by an Alzheimer's Association Post-Award Specialist for accuracy and consistency with the agreed upon budget. In addition, the Association requires protocol continuation approval (i.e., INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC), INSTITUTIONAL REVIEW BOARD (IRB), RECOMBINANT DNA PROTOCAL (RDNA)) annually, if applicable for the research project. Any subsequent payments to grant awardees are generated after the receipt of these documents and approval by the Chief Science Officer, Medical and Scientific Relations. At the conclusion of the award, all reports/publication(s) are due 90 days after the award expires and must be uploaded to the proposalCENTRAL online system. The financial report must be signed by the institutional official who has fiscal responsibility for the award. Publication(s) as accepted are uploaded to proposalCENTRAL during and after the duration of the grant. It is expected that awardees will continue to maintain record of any publication(s) acknowledging the Alzheimer's Association. Data generated as a result of Alzheimer's Association funded work is subject to data sharing, as a condition of award. Data and other outputs of the project are subjected to this policy for quick, reasonable submissions for completed work. Further, Awardees agree to submit/share data, as applicable, through the Global Alzheimer's Association Interactive Network (GAAIN*), a global infrastructure connecting research studies from around the world through one portal where data can be interrogated in aggregate for analysis using a virtual machine. GAAIN is wholly funded by the Alzheimer's Association. In addition, the Association requests, monitors, and follows-up to ensure submission compliance on all awarded grants and that financial reporting requirements are met. Awardees' financial reports are reviewed annually to ensure eligibility for continued funding. Delinquent report(s) may result in the withdrawal of funding. Researchers are informed that delinquent reporting could lead to withdrawal of funding when the request for annual report(s) is sent. If funding is withdrawn due to delinquent reports, any unspent funds must be returned to the Alzheimer's Association. For-profit organizations are not eligible to apply to the Alzheimer's Association's International Research Grant Program, with the exception of the Part the Cloud Translational Research Grant, Alzheimers Innovation Award and certain partnership programs, including Biomarkers Across Neurodegenerative Diseases (BAND) and Tau Pipeline Enabling Program (T-PEP). Eligibility of organizations applicable for a program are detailed in that program's RFA. Unless otherwise stated in program, all institutions are required to submit verification of their non-profit status dated within the last five years (e.g., IRS tax determination letter). If the IRS determination letter is dated prior to this five year period, the institution is required to provide documentation from an authorized signing official in their Grants and Contracts Office or Office of Sponsored Research to confirm there has not been a status change for the organization. For the Part the Cloud Translational Research Grant Program and other programs with for-profit awardees, any for-profit applicant is required to submit the Organization's financial statements. As part of the application process, applicants are required to upload a W-9 form that has been dated and signed by an authorized signing official. This form verifies that an institution or organization is designated as a 501(c)(3) or other non-profit entity. For profit organizations must submit documentation of net assets and annual earnings, in addition to the W-9 form for consideration. These forms are uploaded within their submitted application to proposalCENTRAL. After receipt, these forms are reviewed by an Alzheimer's Association pre-award specialist. Following review by a pre-award specialist, applications are then moved forward to peer-review. If awarded, the Alzheimer's Association post-award specialist includes the appropriate forms in payment requests for grant funding payments. Prior to award confirmation, the Medical and Scientific Relations Division verifies that each Institution is compliant with the U.S. Patriot Act and does not appear on the Specially Designated Nationals (SDN) lists. Prior to payment, each funded Alzheimers Association grant awardee (i.e. the institution) is verified for compliance with the U.S. Patriot Act. The Post Award Specialist confirms eligibility and provides this documentation to the grant online file at proposalCENTRAL prior to payment being sent to the Awardee. In the event that a positive match to one of the SDN lists is found by the Association, it would immediately be reported to the Alzheimers Association legal department for appropriate handling and follow-up. For transactions unrelated to the International Research Grant Program in the Medical and Scientific Department, the same financial documentation is reviewed. The Alzheimer's Association monitors the scientific advances of the Association's grant awardees by maintaining records of publications, presentations, and intellectual property that result from funded studies. The Association requires the grant recipient to notify the Alzheimer's Association on an annual basis with updates to these records. Follow-on funding from federal agencies is also monitored. The Alzheimer's Association granted funds to Alzheimer's Impact Movement (AIM) for public policy division activities in fiscal year 2019 to support priorities identified in the Alzheimer's Association's strategic plan. This grant is restricted to the following 501(c)(3) activities and the ancillary activities necessary to accomplish specific goals including: Implementation of the National Alzheimer's Project Act (Recognizing this growing Alzheimer's crisis, Congress unanimously passed and the President signed into law the National Alzheimer's Project Act - NAPA); increasing the commitment to Alzheimer's research; expanding education efforts and caregiver support services; expanding diagnosis and planning. * These are names that are trademarks to Alzheimer's Association. X true true X X X X X false false false false false false false false false HARRY JOHNS President & CEO 776337 767 181748 0 3605 0 30250 0 22308 0 1014248 767 0 0 RICHARD HOVLAND COO/CFO & ASST. TREAS. 424023 0 125078 0 41105 0 30250 0 30400 0 650856 0 0 0 Maria Carrillo Chief Science Officer 386249 0 109772 0 100484 0 30250 0 4421 0 631176 0 75000 0 ROBERT EGGE CHIEF PUBLIC POLICY OFFICER 354771 20238 109800 0 100484 0 30250 0 34074 0 629379 20238 75000 0 Donna McCullough Chief Development Officer 339640 2104 92858 0 1365 0 55250 0 11204 0 500317 2104 0 0 KENANN CASSIDY EAST AREA LEADER 316009 0 69540 0 3292 0 30250 0 13903 0 432994 0 0 0 Glenda Berry WEST AREA LEADER 313641 0 69540 0 2099 0 30250 0 21819 0 437349 0 0 0 Christine Foh Asst Secy & VP Legal & GC 220266 0 32310 0 1794 0 28323 0 11352 0 294045 0 0 0 SCHEDULE J, PART I, LINE 1A TRAVEL FOR COMPANIONS AT TIMES A BOARD MEMBER WITH EARLY ONSET ALZHEIMER'S DISEASE MAY REQUIRE A COMPANION TO ACCOMPANY HIM OR HER ON BUSINESS TRAVEL FOR SAFETY REASONS. SINCE HIS OR HER INVOLVEMENT IN THE MEETINGS IS CRITICAL TO REPRESENTING KEY CONSTITUENTS AND APPROPRIATELY FULFILLING THE MISSION OF THE ALZHEIMER'S ASSOCIATION, THE EXPENSES OF COMPANION TRAVEL ARE REIMBURSED. SCHEDULE J, PART I, LINE 4B SUPPLEMENTAL NON-QUALIFIED RETIREMENT PLAN THERE WERE NO ADDITIONAL AMOUNTS ACCRUED OR REPORTED FOR HARRY JOHNS OR RICHARD HOVLAND RELATED TO A 457(B) PLAN IN CALENDAR YEAR 2018. SCHEDULE J, PART II, COLUMN (B) (II) SUPPLEMENTAL COMPENSATION INFORMATION: BONUS AND INCENTIVE COMPENSATION HARRY JOHNS RECEIVED PERFORMANCE BASED INCENTIVE COMPENSATION OF $181,748 BASED ON HIS SUCCESSFUL ACHIEVEMENT OF SPECIFIC GOALS, WHICH WERE DEVELOPED, REVIEWED, AND APPROVED BY THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS IN CONSULTATION WITH THE BOARD'S INDEPENDENT THIRD-PARTY COMPENSATION CONSULTANTS. THIS PERFORMANCE BASED INCENTIVE COMPENSATION WAS EARNED FOR PERFORMANCE IN FISCAL YEAR 2018 AND WAS PAID IN CALENDAR YEAR 2018. RICHARD HOVLAND, ROBERT EGGE, MARIA CARRILLO, DONNA MCCULLOUGH, GLENDA BERRY, KENANN CASSIDY, AND CHRISTINE FOH RECEIVED PERFORMANCE BASED INCENTIVES EARNED IN FISCAL YEAR 2018 AND PAID IN CALENDAR YEAR 2018. SCHEDULE J, PART II, COLUMN (B) (III) SUPPLEMENTAL COMPENSATION INFORMATION: OTHER REPORTABLE COMPENSATION RICHARD HOVLAND'S OTHER REPORTABLE COMPENSATION INCLUDES A RETENTION INCENTIVE ACCRUAL OF $37,500 WHICH WAS PAID IN CALENDAR YEAR 2018 AND WAS TIED TO SPECIFIC MULTI-YEAR VESTING REQUIREMENTS THROUGH JUNE 30, 2018, PAYABLE IN JULY 2018. MARIA CARRILLO AND ROBERT EGGE HAVE OTHER REPORTABLE COMPENSATION THAT INCLUDES A RETENTION INCENTIVE ACCRUAL OF $100,000 RESPECTIVELY AND WAS TIED TO SPECIFIC MULTI-YEAR VESTING REQUIREMENTS THROUGH JUNE 30, 2018, PAYABLE IN JULY 2018. HARRY JOHNS AND RICHARD HOVLAND RECEIVE A BASIC LIFE INSURANCE BENEFIT OF ONE TIMES THE ANNUAL SALARY. THE AMOUNT REPRESENTED IN THIS SECTION IS IMPUTED INCOME FOR THE GROUP TERM LIFE BENEFIT. ROBERT EGGE, MARIA CARRILLO, DONNA MCCULLOUGH, GLENDA BERRY, KENANN CASSIDY AND CHRISTINE FOH ALSO RECEIVE THE LIFE INSURANCE BENEFIT. HARRY JOHNS, RICHARD HOVLAND, KENANN CASSIDY, AND CHRISTINE FOH HAVE ADDITIONAL IMPUTED INCOME FOR VOLUNTARY ELECTIONS UNDER THE GROUP DISABILITY PLAN. SCHEDULE J, PART II, COLUMN (C) SUPPLEMENTAL COMPENSATION INFORMATION: RETIREMENT AND OTHER DEFERRED COMPENSATION HARRY JOHNS - RETIREMENT AND OTHER DEFERRED COMPENSATION INCLUDES EMPLOYER CONTRIBUTIONS TO A QUALIFIED BROAD-BASED 401(K) RETIREMENT PLAN - $30,250. RICHARD HOVLAND - RETIREMENT AND OTHER DEFERRED COMPENSATION INCLUDES EMPLOYER CONTRIBUTIONS TO A QUALIFIED 401(K) RETIREMENT PLAN - $30,250. DONNA MCCULLOUGH - RETIREMENT AND OTHER DEFERRED COMPENSATION INCLUDES EMPLOYER CONTRIBUTIONS TO A QUALIFIED 401(K) RETIREMENT PLAN AND A RETENTION INCENTIVE ACCRUAL WHICH WAS NOT PAID AS OF DECEMBER 31, 2018, BUT WHICH IS TIED TO SPECIFIC MULTI-YEAR VESTING REQUIREMENTS THROUGH JANUARY 31, 2020. ROBERT EGGE, MARIA CARRILLO, GLENDA BERRY, KENANN CASSIDY, AND CHRISTINE FOH - RETIREMENT AND OTHER DEFERRED COMPENSATION INCLUDES EMPLOYER CONTRIBUTIONS TO A QUALIFIED 401(K) RETIREMENT PLAN. SCHEDULE J, PART II, COLUMN (D) SUPPLEMENTAL COMPENSATION INFORMATION: NONTAXABLE BENEFITS HARRY JOHNS - NON-TAXABLE BENEFITS OF $22,308 INCLUDE EMPLOYER CONTRIBUTIONS TO MEDICAL, DENTAL, BASIC LIFE INSURANCE, SHORT AND LONG-TERM DISABILITY, AND LONG-TERM CARE INSURANCE BASED ON HIS PERSONAL ELECTIONS FOR CALENDAR YEAR 2018 THROUGH THE BENEFIT OFFERINGS AVAILABLE TO ALL OTHER BENEFITS-ELIGIBLE EMPLOYEES AT OUR ORGANIZATION. THE AMOUNTS REPRESENTED FOR RICHARD HOVLAND, ROBERT EGGE, MARIA CARRILLO, DONNA MCCULLOUGH, GLENDA BERRY, KENANN CASSIDY AND CHRISTINE FOH REPRESENT COMPANY CONTRIBUTIONS TO THE MEDICAL, DENTAL, BASIC LIFE INSURANCE, SHORT AND LONG-TERM DISABILITY, AND LONG-TERM CARE INSURANCE BASED ON INDIVIDUAL ELECTIONS. TANDEM SOLUTIONS FORMER BOARD MEMBER 132276 INDEPENDENT CONTRACTOR false SCHEDULE L, PART IV DESCRIPTION OF BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS ALZHEIMER'S ASSOCIATION HAD A BUSINESS TRANSACTION WITH TANDEM SOLUTIONS, WHICH JOSEPH MCCAFFERTY, A FORMER BOARD MEMBER OF ALZHEIMER'S ASSOCIATION HAS A BUSINESS RELATIONSHIP. JOSEPH MCCAFFERTY RESIGNED FROM THE ALZHEIMER'S ASSOCIATION BOARD ON JULY 7, 2016. FOLLOWING HIS RESIGNATION, MR. MCCAFFERTY'S COMPANY, TANDEM SOLUTIONS, WAS ENGAGED AS AN INDEPENDENT CONTRACTOR BY THE ASSOCIATION. THE BUSINESS TRANSACTION BETWEEN THE ASSOCIATION AND TANDEM SOLUTIONS WAS AN ARM'S LENGTH TRANSACTION. X 500 6610920 FAIR MARKET VALUE X GALA-RELATED NONCASH ITEMS 301 827847 FAIR MARKET VALUE X FUNDRAISING NONCASH ITEMS 167 530511 FAIR MARKET VALUE X MISC NONCASH ITEMS 8 49285 FAIR MARKET VALUE X RAFFLE NONCASH ITEMS 8 12822 FAIR MARKET VALUE false true true SCHEDULE M, PART I, LINE 25 AND LINE 32B THIRD PARTY ASSISTANCE OF NONCASH CONTRIBUTIONS LINE 25 - THE ALZHEIMER'S ASSOCIATION RECEIVES VARIOUS NONCASH CONTRIBUTIONS FOR THEIR FUNDRAISING EVENTS. THESE ITEMS INCLUDE SPORTING TICKETS, JEWELRY, CONCERT TICKETS, DINNERS AND VARIOUS OTHER PACKAGES. LINE 32B - A THIRD PARTY RECEIVES DIRECTLY, SELLS AND REMITS PROCEEDS FROM AUTOMOBILE SALES. Schedule M, Part I, Column B Alzheimer's Association is reporting the dollar amount of noncash contributions as well as the number of items received. Form 990, Part III, Line 1 Organization's Mission, continued THE MISSION OF THE ALZHEIMER'S ASSOCIATION IS TO ELIMINATE ALZHEIMER'S DISEASE THROUGH THE ADVANCEMENT OF RESEARCH; TO PROVIDE AND ENHANCE CARE AND SUPPORT FOR ALL AFFECTED; AND TO REDUCE THE RISK OF DEMENTIA THROUGH THE PROMOTION OF BRAIN HEALTH. THE VISION OF THE ALZHEIMER'S ASSOCIATION IS A WORLD WITHOUT ALZHEIMER'S. THE ALZHEIMER'S ASSOCIATION IS A VALUED RESOURCE FOR CAREGIVERS AND THOSE LIVING WITH THE DISEASE, OFFERING INFORMATION, EDUCATION AND SUPPORT. APPROXIMATELY 290 OFFICES ACROSS THE U.S. ARE DOING BUSINESS AS THE ALZHEIMER'S ASSOCIATION AND VARIOUS NAMES AS A COLLECTION OF 77 CHAPTERS WORKING TO ACCOMPLISH THE MISSION. THE ORGANIZATION IS HEADQUARTERED IN CHICAGO, AND HAS A PUBLIC POLICY OFFICE IN WASHINGTON, D.C. THE ALZHEIMER'S ASSOCIATION PROVIDES 24/7 CONSTITUENT SUPPORT IN OVER 170 LANGUAGES THROUGH THE USE OF A PROFESSIONAL LANGUAGE LINE 365 DAYS A YEAR (1-800-272-3900) AS WELL AS ON OUR WEBSITE, ALZ.ORG*. AS THE LEADING VOLUNTARY HEALTH ORGANIZATION IN CARE, SUPPORT AND RESEARCH, SINCE AWARDING THE FIRST GRANTS IN 1982, THE ASSOCIATION HAS COMMITTED MORE THAN $475 MILLION TO MORE THAN 3,000 BEST-OF-FIELD GRANTS. AS A LEADER IN THE FIELD, THE ALZHEIMER'S ASSOCIATION FOSTERS COLLABORATION OF THE SCIENTIFIC COMMUNITY BY HOSTING THE LARGEST INTERNATIONAL CONFERENCE FOCUSING ON ALZHEIMER'S DISEASE RESEARCH IN THE WORLD. IN ADDITION, THE ALZHEIMER'S ASSOCIATION ADVOCATES FOR THE NEEDS AND RIGHTS OF PEOPLE WITH ALZHEIMER'S, THEIR FAMILIES AND CAREGIVERS, SPEAKING UP TO HELP ENCOURAGE CONGRESS TO TAKE ACTION IN THE FIGHT AGAINST THIS DISEASE, (INCLUDING THROUGH AN ANNUAL ADVOCACY FORUM IN WASHINGTON, D.C.) AND LEADS ADVOCACY EFFORTS IN EVERY STATE. CONCERN ABOUT ALZHEIMER'S DISEASE AND AWARENESS ABOUT THE ASSOCIATION ARE CRITICAL TO ACCELERATING PROGRESS. THE ALZHEIMER'S ASSOCIATION STRIVES TO MAKE MORE PEOPLE AWARE OF THE SERVICES AVAILABLE FOR THOSE FACING THIS DISEASE AND THE BENEFITS OF EARLY DETECTION. (MORE THAN 5 MILLION ALZHEIMER'S ASSOCIATION CONSTITUENTS HAVE SIGNED UP TO EDUCATE, ADVOCATE, DONATE, AND PARTICIPATE TO MOVE THIS CAUSE FORWARD). A DONOR-SUPPORTED ORGANIZATION, THE ALZHEIMER'S ASSOCIATION ALLOCATES ITS FUNDS IN AN ETHICAL AND RESPONSIBLE MANNER THAT EXCEEDS THE RIGOROUS STANDARDS OF AMERICA'S MOST EXPERIENCED CHARITY EVALUATOR, THE BETTER BUSINESS BUREAU WISE GIVING ALLIANCE. THE ASSOCIATION IS QUALIFIED TO USE THE "BBB TORCH LOGOA NATIONAL CHARITY SEAL ("SEAL"). * THESE ARE NAMES THAT ARE TRADEMARKS TO ALZHEIMER'S ASSOCIATION. FORM 990, PART III, LINE 4D OTHER PROGRAM SERVICES ADVOCACY - AS ALZHEIMER'S DISEASE THREATENS TO BANKRUPT FAMILIES, BUSINESSES AND OUR HEALTHCARE SYSTEM, SCIENTISTS ARE MOVING CLOSER TO FINDING BETTER TREATMENTS THAT COULD ALTER THE COURSE OF THE DISEASE. THE ALZHEIMER'S ASSOCIATION ADVOCATES FOR PUBLIC POLICIES AIMED AT ADVANCING RESEARCH TOWARD BETTER THERAPIES, DETECTION, METHODS OF PREVENTION AND ULTIMATELY A CURE, AS WELL AS FOR BETTER CARE AND RESOURCES, AND HEALTH AND LONG-TERM COVERAGE TO ENSURE HIGH QUALITY COST EFFECTIVE CARE FOR PEOPLE WITH ALZHEIMER'S DISEASE AND THEIR FAMILIES. MORE THAN 600,000 GRASS ROOTS ALZHEIMER'S ASSOCIATION ADVOCATES SPEAK UP FOR THE NEEDS AND RIGHTS OF PEOPLE WITH ALZHEIMER'S AND THEIR FAMILIES, AND ENCOURAGE CONGRESS TO INCREASE FUNDING FOR RESEARCH AND CARE. ADVOCACY ACTIVITIES ALSO INCLUDE COLLABORATING WITH OTHER ORGANIZATIONS TO IMPROVE QUALITY CARE AND RAISE AWARENESS OF KEY ISSUES. PATIENT AND FAMILY SERVICES - THE ALZHEIMER'S ASSOCIATION* PROVIDES AN ARRAY OF INFORMATION AND SUPPORT SERVICES DESIGNED SPECIFICALLY FOR INDIVIDUALS WITH ALZHEIMER'S DISEASE, THEIR FAMILIES, FRIENDS AND CAREGIVERS. IN ORDER TO MEET THE DIVERSE NEEDS OF INDIVIDUALS AFFECTED BY ALZHEIMER'S DISEASE, THE ASSOCIATION'S PROGRAMS AND SERVICES ARE OFFERED IN PERSON, BY PHONE AND ONLINE. IN CHAPTERS THROUGHOUT THE COUNTRY, CONSTITUENTS CAN ATTEND EDUCATION PROGRAMS AND SUPPORT GROUPS, RECEIVE PERSONALIZED CARE CONSULTATION, ENGAGE IN EARLY STAGE PROGRAMS, AND ENROLL IN SUPPORT PROGRAMS. IN ORDER TO MEET THE NEEDS OF CONSTITUENTS WHO RELY ON THE WEB FOR INFORMATION AND SUPPORT, THE ASSOCIATION OFFERS A ROBUST CAREGIVER CENTER. WITHIN THE CAREGIVER CENTER, FAMILIES AND CAREGIVERS CAN ACCESS ALZHEIMER'S NAVIGATOR*, AN INNOVATIVE TOOL TO HELP CAREGIVERS AND PEOPLE WITH DEMENTIA EVALUATE THEIR NEEDS, CREATE A CUSTOMIZED ACTION PLAN AND LINK TO INFORMATION, SUPPORT AND LOCAL RESOURCES FOR INDIVIDUALS LIVING WITH ALZHEIMER'S. ALSO AVAILABLE THROUGH THE CAREGIVER CENTER, FOR INDIVIDUALS LOOKING FOR SUPPORT FROM OTHERS LIVING IN SIMILAR SITUATIONS IS ALZCONNECTED*, AN ON-LINE COMMUNITY THAT INCLUDES MULTIPLE FORUMS FOR DIVERSE AUDIENCES. THROUGH THE ASSOCIATION'S HELPLINE, AVAILABLE 24 HOURS A DAY, 7 DAYS A WEEK, 365 DAYS A YEAR, INDIVIDUALS WITH ALZHEIMER'S DISEASE, THEIR FAMILIES AND CAREGIVERS CAN TALK TO A SPECIALIST TO RECEIVE INFORMATION AND BASIC EDUCATION ABOUT THE DISEASE; AND GUIDANCE FOR MORE COMPLICATED OR URGENT SITUATIONS, WITH MASTERS-LEVEL COUNSELORS WHO ARE AVAILABLE TO CONSTITUENTS, ANY TIME, DAY OR NIGHT. ADDITIONALLY, CALLS CAN BE HANDLED IN OVER 170 DIFFERENT LANGUAGES THROUGH THE USE OF A PROFESSIONAL LANGUAGE LINE. ANNUALLY, THE HELPLINE RECEIVES APPROXIMATELY 300,000 CALLS. THE ASSOCIATION'S WEBSITE (WWW.ALZ.ORG*) RECEIVES more than 32 million visits a year. ONLINE PROGRAMS INCLUDE: SELF-SERVICE EDUCATION PROGRAMS, AN ONLINE COMMUNITY, AN INTERACTIVE BRAIN TOUR (AVAILABLE IN 15 LANGUAGES), ACCESS TO COMPREHENSIVE DISEASE INFORMATION, PORTALS IN SPANISH, CHINESE, VIETNAMESE, JAPANESE, AND KOREAN; A VIRTUAL LIBRARY, A SAFETY CENTER, AND A SECTION DEVELOPED SPECIFICALLY FOR PEOPLE LIVING WITH ALZHEIMER'S, WITH INPUT FROM PEOPLE IN THE EARLY STAGES OF ALZHEIMER'S DISEASE AND THEIR CARE PARTNERS. THROUGH THE ASSOCIATION'S EARLY STAGE INITIATIVE, INDIVIDUALS IN THE EARLY STAGES OF THE DISEASE CAN PARTICIPATE IN EDUCATION PROGRAMS, SUPPORT GROUPS AND SOCIAL ENGAGEMENT PROGRAMS. ADDITIONALLY, THE ASSOCIATION CONVENES AN EARLY STAGE ADVISORY GROUP WHOSE MEMBERS RAISE AWARENESS, ADVOCATE FOR THE CAUSE, AND PROVIDE GUIDANCE AND REVIEW OF PROGRAMS AND SERVICES. THE ALZHEIMERS ASSOCIATION HAS LAUNCHED AN INITIATIVE TO WORK WITH HEALTH SYSTEMS, LONG-TERM CARE FACILITIES, AND COMMUNITY-BASED DEMENTIA PROVIDERS WITH EVIDENCE-BASED INFORMATION AND QUALITY IMPROVEMENT PROGRAMMING TO ENHANCE HOW THESE SYSTEMS PROVIDE CARE AND SUPPORT SERVICES. UNIQUE PROGRAMMING OPPORTUNITIES INCLUDE DIRECT TRAINING TO PROVIDERS AND VIDEO-BASED EDUCATION THROUGH PROJECT ECHO. THE PROGRAMS AND SERVICES OF THE ALZHEIMER'S ASSOCIATION ARE DESIGNED TO PROVIDE EDUCATION, INFORMATION, SUPPORT, AND RESOURCES IN ORDER TO HELP INDIVIDUALS WITH ALZHEIMER's, THEIR FAMILIES AND CAREGIVERS NAVIGATE THE LONG AND COMPLICATED JOURNEY THROUGH ALZHEIMER'S DISEASE AND OTHER DEMENTIAS. * THESE ARE NAMES THAT ARE TRADEMARKS TO ALZHEIMER'S ASSOCIATION. FORM 990, PART VI, LINE 1A GOVERNING BODY: THE BOARD OF DIRECTORS OF THE ALZHEIMERS ASSOCIATION IS THE ORGANIZATION'S GOVERNING BODY. THE BOARD HAS DELEGATED AUTHORITY TO ITS STANDING AND OTHER BUSINESS COMMITTEES AS DESCRIBED IN ARTICLE VII OF THE ORGANIZATIONAL BYLAWS. THE FOLLOWING EXCERPT FROM THE ASSOCIATION'S BYLAWS DISCUSS COMMITTEES OF THE BOARD OF DIRECTORS. COMMITTEES OF DIRECTORS: ALL COMMITTEE MEETINGS SHALL BE OPEN TO ATTENDANCE BY ALL DIRECTORS EXCEPT IN EXECUTIVE SESSION. ONLY COMMITTEE MEMBERS MAY VOTE ON COMMITTEE MATTERS. THE BOARD OF DIRECTORS SHALL HAVE THE FOLLOWING STANDING COMMITTEES: EXECUTIVE, FINANCE, GOVERNANCE AND NOMINATING, COMPENSATION, AUDIT AND MISSION OUTCOMES. EXECUTIVE COMMITTEE: THE EXECUTIVE COMMITTEE SHALL MANAGE THE BUSINESS AND PROPERTY OF THE ASSOCIATION IN BETWEEN MEETINGS OF THE BOARD OF DIRECTORS; PROVIDED, THAT THE EXECUTIVE COMMITTEE SHALL NOT TAKE ANY ACTION WHICH IS CONTRARY TO POLICIES OF THE ASSOCIATION AS ADOPTED BY THE BOARD OF DIRECTORS. THE EXECUTIVE COMMITTEE SHALL HAVE SUCH ADDITIONAL POWERS AS MAY BE PROVIDED BY LAW OR RESOLUTION OF THE BOARD OF DIRECTORS. THE EXECUTIVE COMMITTEE SHALL REPORT TO THE BOARD OF DIRECTORS AT EACH MEETING OF THE BOARD OF DIRECTORS AND REPORT EXECUTIVE COMMITTEE ACTIONS IN A TIMELY MANNER IN BETWEEN BOARD OF DIRECTORS MEETINGS. AT EACH OF ITS ANNUAL MEETINGS, THE BOARD OF DIRECTORS BY DULY ADOPTED RESOLUTION SHALL ELECT AN EXECUTIVE COMMITTEE CONSISTING OF NO FEWER THAN SEVEN NOR MORE THAN FIFTEEN DIRECTORS. THE CHAIR, CHAIR ELECT, VICE CHAIRS, SECRETARY, TREASURER, CHAIRS OF THE STANDING COMMITTEES, AND THE CHAIR OF THE MEDICAL AND SCIENTIFIC ADVISORY GROUP, SHALL BE MEMBERS OF THE EXECUTIVE COMMITTEE. THE CHAIR OF THE BOARD OF DIRECTORS SHALL BE THE CHAIR OF THE EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE MAY HOLD REGULAR MEETINGS MONTHLY OR AS IT MAY OTHERWISE DETERMINE, AT SUCH PLACE AND AT SUCH TIMES AND UPON SUCH NOTICE AS IT MAY DETERMINE. SPECIAL MEETINGS OF THE EXECUTIVE COMMITTEE MAY BE CALLED AT ANY TIME BY THE CHAIR OR BY ANY THREE OF ITS MEMBERS, BY NOTICE DELIVERED PERSONALLY OR BY MAIL, TELEPHONE, ELECTRONIC MAIL OR FACSIMILE AT LEAST SEVEN DAYS (OR AT LEAST 48 HOURS IN THE CASE OF TELEPHONIC MEETINGS) PRIOR TO THE MEETING. A MAJORITY OF THE CURRENTLY SERVING MEMBERS OF THE EXECUTIVE COMMITTEE SHALL CONSTITUTE A QUORUM FOR ALL PURPOSES. FINANCE COMMITTEE: THE FINANCE COMMITTEE SHALL CONSIST OF AT LEAST FIVE DIRECTORS AND SHALL BE CHAIRED BY THE TREASURER. THE FINANCE COMMITTEE SHALL OVERSEE AND REVIEW ALL FINANCIAL REPORTS, ACCOUNTING ACTIVITIES AND INVESTMENT DECISIONS OF THE ASSOCIATION AND ALSO SHALL PREPARE A PROJECTED BUDGET FOR EACH FISCAL YEAR TO BE PRESENTED TO THE BOARD OF DIRECTORS FOR APPROVAL. THE FINANCE COMMITTEE SHALL OVERSEE AND MAKE RECOMMENDATIONS TO THE BOARD OF DIRECTORS WITH RESPECT TO THE FINANCIAL OPERATION OF ALZHEIMERS ASSOCIATION 401(K) SAVINGS PLAN AND THE APPOINTMENT OF FIDUCIARIES WITH RESPECT THERETO. GOVERNANCE AND NOMINATING COMMITTEE: AT EACH OF ITS ANNUAL MEETINGS, THE BOARD OF DIRECTORS BY DULY ADOPTED RESOLUTION SHALL ELECT A GOVERNANCE AND NOMINATING COMMITTEE CONSISTING OF NO FEWER THAN SEVEN NOR MORE THAN FIFTEEN INDIVIDUALS CURRENTLY SERVING AS A DIRECTOR. AT LEAST ONE-THIRD OF THE GOVERNANCE AND NOMINATING COMMITTEE SHALL BE DIRECTORS HAVING CHAPTER EXPERIENCE. THE GOVERNANCE AND NOMINATING COMMITTEE SHALL ASSIST THE BOARD IN ENSURING THE SUCCESSFUL GOVERNANCE OF THE ASSOCIATION THROUGH BOARD ASSESSMENT, RECRUITMENT, NOMINATIONS, ORIENTATION AND DEVELOPMENT. THE GOVERNANCE AND NOMINATING COMMITTEE SHALL NOMINATE CANDIDATES FOR DIRECTORS, OFFICERS AND MEMBERS OF THE EXECUTIVE COMMITTEE. THE GOVERNANCE AND NOMINATING COMMITTEE MAY NOMINATE CANDIDATES FOR HONORARY DIRECTOR AND ANY ADVISORY OR HONORARY COUNCILS, GROUPS OR COMMITTEES AND APPROVE THE CANDIDATES FOR MEDICAL AND SCIENTIFIC ADVISORY GROUP MEMBERSHIP. THE GOVERNANCE AND NOMINATING COMMITTEE ALSO SHALL PROVIDE INPUT TO THE CHAIR ON THE SELECTION OF VICE CHAIRS AND COMMITTEE CHAIRS. COMPENSATION COMMITTEE: THE COMPENSATION COMMITTEE SHALL BE RESPONSIBLE FOR REVIEWING AND APPROVING, SUBJECT TO FURTHER AND FINAL APPROVAL BY THE BOARD OF DIRECTORS, ALL FORMS OF COMPENSATION AND BENEFITS FOR THE PRESIDENT AND CHIEF EXECUTIVE OFFICER. THE COMPENSATION COMMITTEE SHALL CONDUCT ITS REVIEW AND APPROVAL OF THE PRESIDENT AND CHIEF EXECUTIVE OFFICERS TOTAL COMPENSATION AND BENEFITS IN A MANNER INTENDED TO QUALIFY FOR THE REBUTTABLE PRESUMPTION OF REASONABLENESS UNDER SECTION 4958 OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED ("SECTION 4958"). THE COMPENSATION COMMITTEE ALSO SHALL BE RESPONSIBLE FOR REVIEWING AND APPROVING APPROPRIATE MARKET DATA, TO BE USED BY THE PRESIDENT AND CHIEF EXECUTIVE OFFICER TO SET OR ADJUST COMPENSATION OF ANY OTHER EXECUTIVE-LEVEL EMPLOYEE WHO COULD BE CONSIDERED TO BE IN A POSITION TO EXERCISE SUBSTANTIAL INFLUENCE OVER THE AFFAIRS OF THE ASSOCIATION WITHIN THE MEANING OF SECTION 4958. THE COMPENSATION COMMITTEE ALSO SHALL BE RESPONSIBLE FOR OVERSIGHT OF EXECUTIVE-LEVEL BENEFITS AND SUCCESSION PLANNING FOR KEY POSITIONS IN THE ASSOCIATION. AUDIT COMMITTEE: THE AUDIT COMMITTEE SHALL BE RESPONSIBLE FOR RECOMMENDING AN AUDITOR TO THE BOARD OF DIRECTORS AND SHALL OVERSEE THE ACTIVITIES OF ANY INTERNAL AUDITOR OF THE ASSOCIATION. THE AUDIT COMMITTEE SHALL SEE THAT AN ANNUAL AUDIT IS PREPARED BY AN INDEPENDENT FIRM OF CERTIFIED PUBLIC ACCOUNTANTS SELECTED BY THE BOARD OF DIRECTORS AND, UPON RECEIVING SUCH AUDITOR'S REPORT, THE AUDIT COMMITTEE SHALL PREVIEW THE AUDIT REPORT FOR SUBMISSION TO THE BOARD OF DIRECTORS EACH YEAR. THE AUDIT COMMITTEE SHALL REVIEW THE FINANCIAL REPORTS OF THE ASSOCIATION, ITS SYSTEM OF INTERNAL CONTROLS, AND THE AUDIT PROCESS. THE AUDIT COMMITTEE SHALL HAVE AT LEAST FIVE MEMBERS, ALL OF WHOM ARE MEMBERS OF THE BOARD OF DIRECTORS AND THE MAJORITY OF WHOM HAVE APPROPRIATE FINANCIAL EXPERTISE. AT LEAST ONE MEMBER OF THE AUDIT COMMITTEE SHALL MEET THE REQUIREMENT OF "AUDIT COMMITTEE FINANCIAL EXPERT" AS THEN DEFINED BY THE SECURITIES AND EXCHANGE COMMISSION. THE MAJORITY OF THE MEMBERS OF THE AUDIT COMMITTEE MAY NOT CONCURRENTLY SERVE ON THE FINANCE COMMITTEE AND THE TREASURER AND CHAIR OF THE FINANCE COMMITTEE MAY NOT SERVE CONCURRENTLY ON THE AUDIT COMMITTEE. MISSION OUTCOMES COMMITTEE: THE MISSION OUTCOMES COMMITTEE SHALL OVERSEE AND REVIEW PROGRESS AGAINST THE ALZHEIMERS ASSOCIATIONS STRATEGIC PLANS PRIORITY ACTIVITIES AND SHALL SUPPORT AND FACILITATE BOARD OF DIRECTORS CONVERSATIONS THAT ARE FOCUSED ON MISSION DELIVERY AND THE APPROVED STRATEGIC PLAN. OTHER COMMITTEES: IN ADDITION TO THE STANDING COMMITTEES, OTHER COMMITTEES MAY BE DESIGNATED BY RESOLUTION ADOPTED BY A MAJORITY OF THE DIRECTORS PRESENT AT ANY MEETING. FORM 990, PART VI, SECTION B, LINE 11B FORM 990 REVIEW PROCESS THE ORGANIZATION UNDERGOES A THOROUGH REVIEW PROCESS BEFORE FILING THE RETURN. THE AUDIT COMMITTEE DISCUSSES AND REVIEWS THE FORM BEFORE IT IS PROVIDED TO THE OFFICERS AND FULL BOARD OF DIRECTORS. ALL OFFICERS AND THE FULL BOARD OF DIRECTORS ARE PROVIDED A COPY FOR THEIR REVIEW AND HAVE THE OPPORTUNITY TO COMMENT BEFORE THE FORM 990 IS FILED. FORM 990, PART VI, LINE 12C CONFLICT OF INTEREST POLICY MONITORING & ENFORCEMENT THE ALZHEIMER'S ASSOCIATION CONFLICT OF INTEREST POLICY IS DESCRIBED IN ARTICLE XI, SECTION 2 OF THE ORGANIZATIONAL BYLAWS. THE RESPONSIBILITY FOR DISCLOSING ANY KNOWN OR REASONABLY FORESEEABLE ACTUAL OR POTENTIAL CONFLICTS OF INTEREST SHALL BE DISCLOSED TO THE BOARD OF DIRECTORS OR ITS COMMITTEE DESIGNEE BY THE INTERESTED PERSON WHOSE INTERESTS ARE OR MAY APPEAR TO BE IN CONFLICT WITH THE ASSOCIATION. ALL INTERESTED PERSONS ARE REQUIRED TO FILE WITH THE ASSOCIATION A DISCLOSURE STATEMENT PRIOR TO SUCH INDIVIDUAL COMMENCING HIS OR HER SERVICE WITH THE ASSOCIATION AND AT SUCH TIME AND IN SUCH MANNER AS MAY BE PROVIDED IN GUIDELINES ADOPTED BY THE BOARD OF DIRECTORS. ALL INTERESTED PERSONS SERVING THE ASSOCIATION SHALL FILE DISCLOSURE STATEMENTS, FROM TIME TO TIME, AS MAY BE REQUIRED BY THE BOARD OF DIRECTORS, THE BYLAWS ARTICLE XI, SECTION 2 OR ANY OTHER BOARD POLICY, AND IN NO EVENT LESS OFTEN THAN ANNUALLY. INTERESTED PERSONS SHALL DISCLOSE ANY CONFLICT AND SHALL NOT VOTE ON A MATTER AND FURTHER IF REQUESTED BY THE CHAIR OR RESOLUTION OF THE BOARD SHALL LEAVE THE ROOM IN WHICH THE BOARD OR COMMITTEE IS MEETING AND SHALL NOT PARTICIPATE IN ANY DELIBERATION OR DECISION REGARDING THE MATTER UNDER CONSIDERATION. THE MINUTES SHALL REFLECT THAT THE CONFLICT OF INTEREST WAS DISCLOSED AND THE INTERESTED PERSON DID NOT PARTICIPATE IN ANY DISCUSSION OF THE MATTER AND DID NOT VOTE ON THE MATTER IN PERSON OR BY PROXY. WHEN ANY SUCH CONFLICT OF INTEREST IS RELEVANT TO A MATTER REQUIRING ACTION BY THE BOARD OF DIRECTORS OR ANY COMMITTEE OF THE BOARD, THE INTERESTED PERSON SHALL DISCLOSE SUCH CONFLICT TO THE BOARD OF DIRECTORS OR SUCH COMMITTEE AND SHALL NOT VOTE ON THE MATTER. FURTHER THE INTERESTED PERSON OR REPRESENTATIVE HAVING A CONFLICT IF REQUESTED BY THE CHAIR OR RESOLUTION OF THE BOARD SHALL LEAVE THE ROOM IN WHICH THE BOARD OR THE COMMITTEE IS MEETING AND SHALL NOT PARTICIPATE IN ANY DELIBERATION OR DECISION REGARDING THE MATTER UNDER CONSIDERATION. WHEN THERE IS A DOUBT AS TO WHETHER A CONFLICT OF INTEREST EXISTS, THE MATTER SHALL BE RESOLVED BY A VOTE OF THE BOARD OF DIRECTORS OR THE COMMITTEE, AS THE CASE MAY BE, EXCLUDING THE INTERESTED PERSON CONCERNING WHOM THE DOUBT HAS ARISEN. COPIES OF THE ASSOCIATION BYLAWS ARTICLE, INCLUDING THE CONFLICT OF INTEREST POLICY AND ANY RELATED ETHICAL POLICY OR GUIDELINES AS FROM TIME TO TIME ADOPTED OR AMENDED BY THE BOARD OF DIRECTORS, SHALL BE PRESENTED TO ALL INTERESTED PERSONS SERVING THE ASSOCIATION AT THE TIME OF ANY SUCH ADOPTION OR AMENDMENT AND IN NO EVENT LESS OFTEN THAN ANNUALLY; AND TO ALL INDIVIDUALS SEEKING TO SERVE THE ASSOCIATION AS AN INTERESTED PERSON PRIOR TO REQUESTING ANY SUCH INDIVIDUAL TO EXECUTE A CONFLICT OF INTEREST DISCLOSURE STATEMENT. FORM 990, PART VI, LINES 15A & 15B PROCESS FOR DETERMINING COMPENSATION COMPENSATION IS ESTABLISHED FOR THE CEO BY THE COMPENSATION COMMITTEE AND THE EXECUTIVE COMMITTEE AFTER A THOROUGH SALARY/MARKET REVIEW CONDUCTED BY OUTSIDE COMPENSATION CONSULTANTS. FOR THE CEO POSITION, THE GATHERING OF RELEVANT COMPARABILITY DATA FROM INDEPENDENT SOURCES OCCURRED IN 2018. THE PROCESS WAS CONDUCTED IN A MANNER INTENDED TO QUALIFY FOR THE REBUTTABLE PRESUMPTION OF REASONABLENESS UNDER THE INTERMEDIATE SANCTIONS RULES. AS TO THE MEMBERS OF THE SENIOR MANAGEMENT TEAM OTHER THAN THE CEO, ANNUALLY UPDATED MARKET DATA IS ALSO PROVIDED BY THE OUTSIDE COMPENSATION CONSULTANT, SO THAT THE UPDATED MARKET DATA CAN BE USED IN SETTING REASONABLE COMPENSATION FOR EACH MEMBER OF THE SENIOR MANAGEMENT TEAM. EACH YEAR THE COMPENSATION COMMITTEE EVALUATES THE CEO'S PERFORMANCE THROUGH A ROBUST ASSESSMENT PROCESS WHICH INCLUDES COLLECTION, INTERVIEWS AND PERFORMANCE EVALUATION COMPARING RESULTS TO GOALS. THE COMMITTEE AND CHAIR OF THE BOARD USE THIS DATA TO DETERMINE INCENTIVE COMPENSATION ELIGIBILITY. THE SENIOR STAFF HAS A COMPREHENSIVE PERFORMANCE EVALUATION AND COMPENSATION REVIEW DONE AT THE END OF EACH FISCAL YEAR. THESE INCLUDE A SELF-ASSESSMENT AND EVALUATION BY THE CEO. UPDATED MARKET DATA FOR USE IN SETTING REASONABLE COMPENSATION IS PROVIDED BY A NATIONAL COMPENSATION CONSULTING FIRM TO THE COMPENSATION COMMITTEE FOR CONFIRMATION OF REASONABLENESS USING A PROCESS DESIGNED TO QUALIFY FOR THE REBUTTABLE PRESUMPTION OF REASONABLENESS (INCLUDING CONTEMPORANEOUS DOCUMENTATION IN THE COMMITTEE'S MINUTES). FOR FISCAL YEAR 2019, THE SALARY AND TOTAL COMPENSATION PACKAGE OF THE CEO WAS BENCHMARKED BY SULLIVAN COTTER. COMPENSATION IS CONTEMPORANEOUSLY DOCUMENTED IN THE COMPENSATION COMMITTEE MINUTES. FORM 990, PART VI, LINE 18 HOW DOCUMENTS ARE MADE AVAILABLE TO THE PUBLIC THE ORGANIZATION MAKES ITS FORM 990 AVAILABLE TO THE GENERAL PUBLIC BY POSTING ON THE WEBSITE AT WWW.ALZ.ORG AND UPON REQUEST. THE ORGANIZATION MAKES ITS FORM 1023 AVAILABLE TO THE GENERAL PUBLIC UPON REQUEST. FORM 990, PART VI, LINE 19 HOW DOCUMENTS ARE MADE AVAILABLE TO THE PUBLIC THE ORGANIZATION'S AUDITED FINANCIAL STATEMENTS ARE MADE AVAILABLE TO THE GENERAL PUBLIC BY POSTING ON THE ORGANIZATION'S WEBSITE AT WWW.ALZ.ORG AND UPON REQUEST. THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY AVAILABLE TO THE GENERAL PUBLIC UPON REQUEST. FORM 990, PART XI, LINE 9 OTHER CHANGE IN NET ASSETS OR FUND BALANCE CHANGE IN PERPETUAL TRUST $(281,426) CHANGE IN SPLIT INTEREST $(1,792,580) ------------ TOTAL $(2,074,006) General Note EFFECTIVE JULY 1, 2016, ONE CHAPTER DISSOLVED AND 46 CHAPTERS MERGED WITH THE ASSOCIATION TO CREATE A UNITED ALZHEIMERS ASSOCIATION. TOTAL ASSETS ACQUIRED FROM THE 47 CHAPTERS WERE APPROXIMATELY $152,004,000 AND NET ASSETS ACQUIRED WERE APPROXIMATELY $130,859,000. THE ASSOCIATION OVERSEES THE OPERATIONS AND ACTIVITIES FOR 77 CHAPTERS TO FACILITATE STRATEGIC ALIGNMENT, DELIVER ON THE OVERARCHING ASSOCIATION-WIDE STRATEGIC OBJECTIVES AND PRIORITY ACTIVITIES, AND TO ENSURE COVERAGE FOR ALL GEOGRAPHIC TERRITORIES. Alzheimer's Impact Movement (AIM) 225 N Michigan Ave Fl 17 Chicago IL 60601 271961435 SOC Welfare IL 501(C)(4) Alz Assoc true Alzheimer's Association International 181 Bay St Brookfield Pl 2100 Toronto Ontario CA M5J2T3 999999999 PUBLIC FDN CA 501(C)(3) Alz Assoc true Coalition of NY State Alz Assn Chaps Inc 4 Pine West Plaza 405 Albany NY 12205 134076596 Public Char NY 501(c)(3) Alz Assoc true false true false false false false false false false false false false true true false false false false Alzheimer's Impact Movement B 7053868 FMV Alzheimer's Impact Movement n 400133 FMV Alzheimer's Impact Movement o 3124184 fmv Schedule R, Part V, Line 2 AMOUNT INVOLVED IN RELATIONSHIP THE ALZHEIMER'S ASSOCIATION GRANTED FUNDS TO ALZHEIMER'S IMPACT MOVEMENT (AIM) FOR PUBLIC POLICY DIVISION ACTIVITIES IN FISCAL YEAR 2019 TO SUPPORT PRIORITIES IDENTIFIED IN THE ALZHEIMER'S ASSOCIATION'S STRATEGIC PLAN. THIS GRANT IS RESTRICTED TO THE FOLLOWING 501(C)(3) ACTIVITIES AND THE ANCILLARY ACTIVITIES NECESSARY TO ACCOMPLISH SPECIFIC GOALS INCLUDING: IMPLEMENTATION OF THE NATIONAL ALZHEIMER'S PROJECT ACT (RECOGNIZING THIS GROWING ALZHEIMER'S CRISIS, CONGRESS UNANIMOUSLY PASSED AND THE PRESIDENT SIGNED INTO LAW THE NATIONAL ALZHEIMER'S PROJECT ACT - NAPA); INCREASING THE COMMITMENT TO ALZHEIMER'S RESEARCH; EXPANDING EDUCATION EFFORTS AND CAREGIVER SUPPORT SERVICES; EXPANDING DIAGNOSIS AND PLANNING.